These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8761297

  • 1. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson RB.
    Oncogene; 1996 Aug 15; 13(4):757-65. PubMed ID: 8761297
    [Abstract] [Full Text] [Related]

  • 2. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.
    Cell Growth Differ; 1995 Jun 15; 6(6):737-48. PubMed ID: 7669729
    [Abstract] [Full Text] [Related]

  • 3. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS.
    Am J Pathol; 1996 Aug 15; 149(2):407-28. PubMed ID: 8701981
    [Abstract] [Full Text] [Related]

  • 4. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

  • 5. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME, Pierce RH, Fausto N.
    Cancer Res; 2001 Jan 15; 61(2):594-601. PubMed ID: 11212255
    [Abstract] [Full Text] [Related]

  • 6. Role for Bcl-xL in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells.
    Nass SJ, Li M, Amundadottir LT, Furth PA, Dickson RB.
    Biochem Biophys Res Commun; 1996 Oct 03; 227(1):248-56. PubMed ID: 8858133
    [Abstract] [Full Text] [Related]

  • 7. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

  • 8. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK, Earp HS, Russell WE, Smith GJ, Grisham JW.
    Cell Growth Differ; 1995 Mar 28; 6(3):251-61. PubMed ID: 7794793
    [Abstract] [Full Text] [Related]

  • 9. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB.
    Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672
    [Abstract] [Full Text] [Related]

  • 10. TGF beta regulation of cell proliferation.
    Moses HL, Arteaga CL, Alexandrow MG, Dagnino L, Kawabata M, Pierce DF, Serra R.
    Princess Takamatsu Symp; 1994 Mar 02; 24():250-63. PubMed ID: 8983080
    [Abstract] [Full Text] [Related]

  • 11. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
    Calvisi DF, Ladu S, Factor VM, Thorgeirsson SS.
    Carcinogenesis; 2004 Jun 02; 25(6):901-8. PubMed ID: 14742323
    [Abstract] [Full Text] [Related]

  • 12. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
    Factor VM, Jensen MR, Thorgeirsson SS.
    Hepatology; 1997 Dec 02; 26(6):1434-43. PubMed ID: 9397983
    [Abstract] [Full Text] [Related]

  • 13. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
    Calvisi DF, Thorgeirsson SS.
    Toxicol Pathol; 2005 Dec 02; 33(1):181-4. PubMed ID: 15805070
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS, Arsura M.
    Mol Cancer Res; 2005 Jul 02; 3(7):403-12. PubMed ID: 16046551
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ, Dickson RB.
    Clin Cancer Res; 1998 Jul 02; 4(7):1813-22. PubMed ID: 9676860
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.
    Smith GH, Sharp R, Kordon EC, Jhappan C, Merlino G.
    Am J Pathol; 1995 Oct 02; 147(4):1081-96. PubMed ID: 7573353
    [Abstract] [Full Text] [Related]

  • 17. Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis.
    Nørgaard P, Law B, Joseph H, Page DL, Shyr Y, Mays D, Pietenpol JA, Kohl NE, Oliff A, Coffey RJ, Poulsen HS, Moses HL.
    Clin Cancer Res; 1999 Jan 02; 5(1):35-42. PubMed ID: 9918200
    [Abstract] [Full Text] [Related]

  • 18. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
    Christensen JG, Goldsworthy TL, Cattley RC.
    Mol Carcinog; 1999 Aug 02; 25(4):273-84. PubMed ID: 10449034
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.
    Jäger R, Herzer U, Schenkel J, Weiher H.
    Oncogene; 1997 Oct 09; 15(15):1787-95. PubMed ID: 9362445
    [Abstract] [Full Text] [Related]

  • 20. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
    Raafat A, Zoltan-Jones A, Strizzi L, Bargo S, Kimura K, Salomon D, Callahan R.
    Oncogene; 2007 Feb 01; 26(5):662-72. PubMed ID: 16878155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.